Flow and image cytometry support for cancer research at a major cancer center
Official title: Associate-Director Flow and Image Cytometry Roswell Park ComprehensiveCancer Center
Funded at Roswell Park Cancer Institute Corp · NIH-11381201 · Data updated 2026-11-12
A dedicated expert in flow and image cytometry provides ongoing support to researchers at Roswell Park Comprehensive Cancer Center to accelerate cancer research projects.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Roswell Park Cancer Institute Corp NIH-funded |
| Lab location | 1 site (Buffalo, United States) |
| Project start | September 20, 2016 |
| Project end | August 31, 2027 |
| Funding year | 2026 |
| Award (this year) | $342,107 |
| NIH project number | 5R50CA211108-10 |
| Project ID | NIH-11381201 on NIH RePORTER |
Who could benefit from this research
✓Could help
Researchers and their cancer patients may indirectly benefit through faster and more precise cancer research outcomes.
✕Less likely to help
Patients will not directly participate in this grant, which funds a core facility position.
What this research studies
This grant funds the salary of the associate director who oversees the Flow and Image Cytometry Shared Resource, helping researchers use imaging and flow cytometry tools for their cancer studies. The role includes collaborations and consultations to apply these techniques effectively across NIH-funded projects. The resource serves multiple program areas within the cancer center, enabling scientists to generate and analyze complex cellular data. The aim is to sustain high-quality cytometry services that advance cancer research and collaboration.
Why it matters
Potential benefit: Researchers can rely on expert cytometry support to generate robust data that may lead to new cancer insights and therapies.
How similar studies have gone: Other cancer centers rely on shared cytometry cores to enable NIH-funded research with demonstrated benefits in data quality and collaboration.
Where this research is happening
-
Roswell Park Cancer Institute Corp
Buffalo, United States Active
Researchers
- Principal investigator: Minderman, Hans — Roswell Park Cancer Institute Corp
- Study coordinator: Minderman, Hans
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.